Michael G Bronfein insider trades: BioScrip (BIOS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2017 | BIOS | ↓ Sell | 27,000 | $2.69 | $73K | Direct | Sep 19, 2017 (4d) |
| Jun 17, 2016 | BIOS | ↑ Buy | 80,000 | $2.50 | $200K | Direct | Jun 20, 2016 (3d) |
| Aug 31, 2007 | VOCS | ↓ Sell | 17,887 | $25.01 | $447K | By Sterling Venture, Partners, LP | Sep 4, 2007 (4d) |
| Aug 30, 2007 | VOCS | ↓ Sell | 46,707 | $25.84 | $1.2M | By Sterling Venture, Partners, LP | Aug 31, 2007 (1d) |
| Aug 28, 2007 | VOCS | ↓ Sell | 54,400 | $25.69 | $1.4M | By Sterling Venture, Partners, LP | Aug 29, 2007 (1d) |
| Aug 22, 2007 | VOCS | ↓ Sell | 80,100 | $25.52 | $2.0M | By Sterling Venture, Partners, LP | Aug 22, 2007 (0d) |
| Aug 13, 2007 | VOCS | ↓ Sell | 61,000 | $27.56 | $1.7M | By Sterling Venture, Partners, LP | Aug 14, 2007 (1d) |
| Jul 30, 2007 | VOCS | ↓ Sell | 21,935 | $29.05 | $637K | By Sterling Venture, Partners, LP | Aug 1, 2007 (2d) |
| Apr 11, 2007 | VOCS | ↓ Sell | 421,007 | $19.50 | $8.2M | By Sterling Venture, Partners, LP | Apr 12, 2007 (1d) |
| Nov 29, 2006 | VOCS | ↑ Buy | 5,000 | $16.75 | $84K | Direct | Dec 1, 2006 (2d) |
| Nov 28, 2006 | EICU | ↑ Buy | 10,000 | $9.30 | $93K | Direct | Nov 29, 2006 (1d) |
| Nov 7, 2006 | EICU | ↓ Sell | 425,000 | $9.84 | $4.2M | Indirect | Nov 9, 2006 (2d) |
| Nov 7, 2006 | VOCS | ↓ Sell | 43,667 | $16.97 | $741K | By Sterling Venture, Partners, LP | Nov 9, 2006 (2d) |
| Oct 30, 2006 | VOCS | ↓ Sell | 311,802 | $16.07 | $5.0M | By Sterling Venture, Partners, LP | Oct 31, 2006 (1d) |
| Aug 17, 2006 | VOCS | ↓ Sell | 257,749 | $13.75 | $3.5M | By Sterling Venture, Partners, LP | Aug 21, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael G Bronfein's insider trades
Michael G Bronfein is a director at BioScrip (BIOS). Since Aug 17, 2006, Michael has reported 3 open-market purchases worth $376K and 12 sales worth $29.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), conversions (2 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.